1. Home
  2. INDP vs TSQ Comparison

INDP vs TSQ Comparison

Compare INDP & TSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

N/A

Current Price

$1.53

Market Cap

125.2M

Sector

Health Care

ML Signal

N/A

TSQ

Townsquare Media Inc.

HOLD

Current Price

$5.54

Market Cap

105.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDP
TSQ
Founded
2000
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
125.2M
105.4M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
INDP
TSQ
Price
$1.53
$5.54
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$11.50
AVG Volume (30 Days)
844.5K
70.5K
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
12.80%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$427,380,000.00
Revenue This Year
N/A
$2.22
Revenue Next Year
N/A
$0.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.92
$4.30
52 Week High
$8.57
$7.97

Technical Indicators

Market Signals
Indicator
INDP
TSQ
Relative Strength Index (RSI) 47.88 38.60
Support Level $0.92 $5.34
Resistance Level $1.58 $5.94
Average True Range (ATR) 0.15 0.21
MACD 0.06 0.01
Stochastic Oscillator 55.57 0.00

Price Performance

Historical Comparison
INDP
TSQ

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

About TSQ Townsquare Media Inc.

Townsquare Media Inc is a radio, digital media, entertainment, and digital marketing solutions company principally focused on being the local advertising and marketing solutions platform in small and mid-sized markets across the United States. It has three segments which are Subscription Digital Marketing Solutions, Digital Advertising, and Broadcast Advertising. It earns the majority of the revenue from the Broadcasting Advertising segment, which includes its local, regional, and national advertising products and solutions delivered via terrestrial radio broadcast. Its portfolio includes local media brands such as WYRK.com, WJON.com, and NJ101.5.com, and national music brands such as XXLmag.com, TasteofCountry.com, UltimateClassicRock.com, and Loudwire.com.

Share on Social Networks: